Categories
| Category | |
|---|---|
| Health Conditions and Concerns | 50% |
| Pharmacy | 38% |
| Biotechnology and Pharmaceuticals | 12% |
Explore sites in same category:
- ogorimii-med.net Rank 1.4M. Estimated value 1,512$
- ocrahope.org Rank 781.7K. Estimated value 2,760$
- myvision.org Rank 439.1K. Estimated value 4,932$
- gluten.org Rank 887.9K. Estimated value 2,424$
- veri.co Rank 646.5K. Estimated value 3,336$
- kesimpta.com Rank 1.3M. Estimated value 1,668$
- dr-hips.com Rank 1M. Estimated value 2,232$
- ito-jibika.net Rank 1.1M. Estimated value 1,968$
- presspogo.com Rank 663.9K. Estimated value 3,252$
- myeczemateam.com Rank 1.5M. Estimated value 1,392$
Keyword Suggestion
Domain Informations
Imfinzi.com lookup results from whois.corporatedomains.com server:
- Domain created: 2015-04-30T20:29:37Z
- Domain updated: 2022-04-26T05:09:37Z
- Domain expires: 2023-04-30T20:29:37Z 0 Years, 29 Days left
- Website age: 7 Years, 335 Days
- Registrar Domain ID: 1924841632_DOMAIN_COM-VRSN
- Registrar Url: http://cscdbs.com
- Registrar WHOIS Server: whois.corporatedomains.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 8887802723
- Name server:
- NS-1417.AWSDNS-49.ORG
- NS-151.AWSDNS-18.COM
- NS-1705.AWSDNS-21.CO.UK
- NS-724.AWSDNS-26.NET
Network
- inetnum : 18.160.0.0 - 18.161.255.255
- name : AMAZON-CF
- handle : NET-18-160-0-0-1
- status : Reallocated
- created : 1995-01-23
- changed : 2022-09-30
Owner
- organization : Amazon.com, Inc.
- handle : AMAZON-4
- address : Array,SEATTLE,WA,98101-1244,US
Technical support
- handle : ANO24-ARIN
- name : Amazon EC2 Network Operations
- phone : +1-206-555-0000
- email : [email protected]
Abuse
- handle : AEA8-ARIN
- name : Amazon EC2 Abuse
- phone : +1-206-555-0000
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 18.160.41.120
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 18.160.41.120)
Spam Check (IP: 18.160.41.120)
Websites Listing
We found Websites Listing below when search with imfinzi.com on Search Engine
IMFINZI (durvalumab) Access & Reimbursement Guide
IMFINZI can cause immune-mediated pneumonitis, defined as requiring use of corticosteroids. Fatal cases have been reported. Monitor patients for signs and symptoms of pneumonitis and evaluate with radiographic imaging when suspected. Administer corticosteroids for Grade 2 or greater pneumonitis. Withhold IMFINZI for Grade 2 pneumonitis; permanently discontinue for …
Imfinzihcp.comImmunotherapy for NSCLC & ES-SCLC | For HCPs | …
IMFINZI can cause severe or life-threatening infusion-related reactions. Monitor for signs and symptoms of infusion-related reactions. Interrupt, slow the rate of, or permanently discontinue IMFINZI based on the severity. See Dosing and Administration for specific details. For Grade 1 or 2 infusion-related reactions, consider using pre-medications with subsequent doses. Infusion …
Imfinzihcp.comPRODUCT MONOGRAPH IMFINZI IMFINZI, indicated for
IMFINZI 20 mg/kg in combination with chemotherapy every 3 weeks (21 days) for 4 cycles, followed by 20 mg/kg every 4 weeks as monotherapy until weight increases to greater than 30 kg. Administer IMFINZI prior to chemotherapy when given on the same day. Please also refer to the full prescribing information for etoposide, carboplatin or cisplatin, in their respective Product …
Astrazeneca.caIMFINZI - pdf.hres.ca
IMFINZI (durvalumab) indicated for the treatment of patients with: Locally advanced or metastatic urothelial carcinoma who: o Have disease progression during or following platinum-containing chemotherapy o Have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy has been issued marketing authorization with …
Pdf.hres.caTo Imfinzi & Beyond… – KATHY WITH A "C"
2018-08-29 · Thursday, August 8, 2018 – Imfinzi #9. I met with Dr. H and we discussed my breathing and the anxiety issues that have come along with it. He believes the root problem is from the Imfinzi infusion messing with the scar tissue on my lung from the radiation, and the anxiety is a result of not being able to take a full breath. Based on this, he ...
Katcoonrod.comImfinzi plus chemotherapy significantly improved overall ...
2021-10-25 · Imfinzi plus chemotherapy was well tolerated, ... Save my name, email, and website in this browser for the next time I comment. - Advertisment - Most Popular. CDC endorses ACIP’s updated COVID-19 vaccine recommendations. December 17, 2021. Launch of UN Group of Friends on Neglected Tropical Diseases and on Support of Water . December 17, 2021. …
Lifepronow.comReference ID: 4223035
IMFINZI can cause immune-mediated pneumonitis, defined as requiring use of corticosteroids. Fatal cases have been reported. Monitor patients for signs and symptoms of pneumonitis. Evaluate patients with suspected pneumonitis with radiographic imaging. Administer corticosteroids, prednisone 1 to 2 mg per kg per day or equivalent for moderate (Grade 2) …
Accessdata.fda.govSavolitinib and IMFINZI Trial for RCC Begins - Patient Worthy
2021-11-30 · IMFINZI (durvalumab) is an intravenously administered human monoclonal antibody that works by binding to PD-L1 and preventing it from interacting with PD-1 or CD80, types of proteins. Through this process, IMFINZI stops the tumor from evading the immune system. Currently, IMFINZI is approved in varying countries for the treatment of patients with …
Patientworthy.comFirst and Only Immuno-Oncology Treatment, Imfinzi ...
2018-05-08 · Imfinzi is a fully human monoclonal antibody that binds to PD-L1 and blocks the interaction of PD-L1 with PD-1 and CD80, countering the tumour's immune-evading tactics and releasing the inhibition of immune responses. Imfinzi has already been granted Notice of Compliance with Conditions (NOC/c) in Canada for the treatment of patients with locally …
Astrazeneca.caabout-imfinzi-durvalumab - For HCPs
IMFINZI can cause severe or life-threatening infusion-related reactions. Monitor for signs and symptoms of infusion-related reactions. Interrupt, slow the rate of, or permanently discontinue IMFINZI based on the severity. See Dosing and Administration for specific details. For Grade 1 or 2 infusion-related reactions, consider using pre-medications with subsequent doses. Infusion …
Imfinzihcp.comMONOGRAPHIE AVEC RENSEIGNEMENTS DESTINÉS AUX PATIENTS
Monographie d’IMFINZI®. COPYRIGHT 2017 –2021, ASTRAZENECA CANADA INC. Page 1de 59 MONOGRAPHIE AVEC RENSEIGNEMENTS DESTINÉS AUX PATIENTS IMFINZI® durvalumab pour injection Concentré en solution pour perfusion, 50 mg / mL, Perfusion intraveineuse Norme reconnue Antinéoplasique, anticorps monoclonal AstraZeneca Canada Inc.
Astrazeneca.caImfinzi.be
IMFINZI is een handelsmerk van de AstraZeneca-bedrijvengroep. ©2018 AstraZeneca. Alle rechten voorbehouden. NS ID XL 0646-RD01/2019-WEB. Local code 103. Terug naar boven × ...
Imfinzi.beGlobal Imfinzi Market Scope 2021 Growth Rate and Major ...
2021-12-13 · MarketsandResearch.biz provides a comprehensive research report on Global Imfinzi Market from 2021 to 2027 that provides a spot-on examination of critical drivers, and flow of the market, and potential market development. The report provides vital data and research to help shape ideal business systems and choose the expert route to improve the essential parts …
Woodlandreport.comImfinzi - Europa
Imfinzi . Procedural steps taken and scientific information after the authorisation . Application number Scope Opinion/ Notification. 1. issued on . Commission Decision Issued. 2 / amended on Product Information affected: 3: Summary : IB/0031/G This was an application for a group of variations. B.II.f.1.b.3 - Stability of FP - Extension of the shelf life of the finished product - After ...
Ema.europa.euSamsung Biologics to manufacture AstraZeneca's Covid ...
2021-12-14 · Save my name, email, and website in this browser for the next time I comment. Δ . Tel: 905-673-6625 Tel: 416-900-6669 Fax: 905-673-6636 Ad Sales Email: [email protected] Website: www.canindia ...
Canindia.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| tv2box.com | 1api.net | 327 Days |
| hungry-bear.net | gmo.jp | 312 Days |
| curiouscat.net | ait.com | 6 Years, 162 Days |
| hcaofsylva.org | enom.com | -1 Years, -12 Days |
| qtraxweb.com | godaddy.com | 92 Days |
| wikijay.com | namecheap.com | -1 Years, -47 Days |
| juditanews.com | netowl.jp | 12 Days |
| dnares.in | godaddy.com | 3 Years, 121 Days |
| oliveltd.com | godaddy.com | 321 Days |
| nftown.com | namecheap.com | 296 Days |